West Pharmaceutical Services Inc. buy UBS Group AG
Start price
25.07.25
/
50%
€226.50
Target price
25.07.26
€272.54
Performance (%)
28.08%
Price
09.06.26
€290.10
Summary
This prediction is currently active. The prediction currently has a performance of 28.08%. This prediction currently runs until 25.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| West Pharmaceutical Services Inc. | 8.085% | 8.085% |
| iShares Core DAX® | -2,20 % | 0,67 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % |
| iShares S&P 500 | -1,67 % | 2,40 % |
Comments by UBS_Group_AG for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€208.70
13.02.26
13.02.26
-
13.02.27
13.02.27
39.00%
09.06.26
09.06.26
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€310.00
12.12.24
12.12.24
€372.22
12.12.25
12.12.25
-27.03%
13.12.25
13.12.25